Scientists identify body's microreactors for innate immunity

July 6, 2018 by Deborah Wormser, UT Southwestern Medical Center
UTSW scientists identify body's microreactors for innate immunity
(l-r) Mingjian Du and Dr. Zhijian "James" Chen. Credit: UT Southwestern

A DNA-sensing enzyme forms droplets that act as tiny bioreactors creating molecules to stimulate innate immunity—the body's first response to infection, UT Southwestern researchers report. The work, reported today in the journal Science, could lead to novel treatments for infections, autoimmune disease, and cancer.

A hallmark of all three of those illnesses is the presence of DNA—either foreign or self—in the cell's gel-like interior known as the cytoplasm, said Dr. Zhijian "James" Chen, Professor of Molecular Biology at UT Southwestern, a Howard Hughes Medical Institute Investigator, and senior author of the study. The study's lead author is graduate student Mingjian Du.

In 2012, Dr. Chen's laboratory discovered the enzyme cyclic GMP-AMP synthase (cGAS), which acts as a sensor in a cellular alarm system for innate immunity. The body has two immune systems. The first is an inborn, or innate, immune system that guards the body against threats it first encounters. The second is the adaptive immune system that deploys specialized immune cells to eradicate pathogens.

The innate immunity sensor cGAS sounds the alarm when it encounters DNA—either from pathogens or from the body's own cells in the case of autoimmune disease—in areas of the cell where that genetic material should not be. Dr. Chen also identified the small molecule cGAMP, which is produced by the enzyme cGAS and functions as a secondary messenger that triggers responses.

The current study finds that when cGAS encounters pathogenic DNA, it binds with the DNA to create droplet-size, microreactors that hold together despite the lack of a membrane. The study identifies the mechanism that holds the droplets together as liquid phase separation, which is similar to the way oil separates from vinegar after a bottle of salad dressing is shaken.

"The droplets act as microreactors to speed up reactions that churn out the small molecule cGAMP, which activates the immune system," Dr. Chen said.

"With a detailed understanding of the pathway, it will be possible to develop and design a variety of drugs for cancer and other diseases," said Dr. Chen, Director of the Center for Inflammation Research and a member in the Center for the Genetics of Host Defense who holds the George L. MacGregor Distinguished Chair in Biomedical Science. "Several companies are working on potential treatments now. For autoimmune diseases such as lupus—in which cGAS is aberrantly turned on by self-DNA in the cell's interior—the goal is to find cGAS inhibitors. With infections, it would be good to enhance the body's immune defense. There is also the hope of finding drugs that stimulate the cGAS pathway to boost the effects of cancer immunotherapy."

In the study, Du and Chen found a threshold effect in the cGAS system. In test-tube studies they found that although DNA and cGAS are both needed to kick off the formation of membraneless droplets, a tiny amount of either DNA or the enzyme fails to sound the alarm.

When the levels of both DNA and cGAS reach a threshold, the liquid droplets form and the pathway kicks into gear. This threshold response allows cGAS to tolerate low levels of self-DNA that may come into contact with the enzyme inside the cells but to trigger a rigorous response when the DNA reaches a threshold level, such as in the case of viral infections, he said.

This mechanism ensures that the immune system can fight infections without causing autoimmune reactions in healthy individuals. However, in some individuals who have elevated levels of self-DNA that come into contact with cGAS in their cells, autoimmune diseases can occur, Dr. Chen added.

"We previously studied a mouse model of autoimmune disease. In an experiment in which we could remove 50 percent of the cGAS enzyme, we found that doing so completely cured the disease in mice. Previously, that finding was difficult to explain. Now, this new model of a threshold effect for cGAS-DNA phase separation explains the finding," Dr. Chen said.

Explore further: A switch for autoimmunity

More information: Mingjian Du et al, DNA-induced liquid phase condensation of cGAS activates innate immune signaling, Science (2018). DOI: 10.1126/science.aat1022

Related Stories

A switch for autoimmunity

October 13, 2017
When a virus or bacteria comes calling, protein "sensors" in your cells can detect the invader's DNA and activate inflammatory responses to prevent infection. One such sensor is cGAS (cyclic GMP-AMP synthase).

Researchers identify an enzyme as a major culprit of autoimmune diseases

October 27, 2015
Activating an enzyme that sounds an alarm for the body's innate immune system causes two lethal autoimmune diseases in mice, while inhibiting the same enzyme rescues them, UT Southwestern Medical Center researchers report.

Researchers identify new enzyme that acts as innate immunity sensor

February 15, 2013
Two studies by researchers at UT Southwestern Medical Center could lead to new treatments for lupus and other autoimmune diseases and strengthen current therapies for viral, bacterial, and parasitic infections.

DNA sensor plays critical role in cancer immunotherapy via response to unexpected DNA form

August 24, 2017
UT Southwestern Medical Center researchers report for the first time that tumors stressed by cancer immunotherapy release their mitochondrial DNA into nearby immune cells, triggering a host alert system.

Scientists find mechanism that triggers immune responses to DNA

December 21, 2012
(Medical Xpress)—Free-floating pieces of DNA in a cell's watery interior can mean bad things: invading viruses, bacteria, or parasites, ruptured cellular membranes, or disease. Genetic material is meant to be contained ...

Cell senescence is regulated by innate DNA sensing

July 31, 2017
Cells in the body or in cultures eventually stop replicating. This phenomenon is called "senescence" and is triggered by shortening of telomeres, oxidative stress or genetic damage to the cells, either acute or simply due ...

Recommended for you

Paracetamol use in infancy is linked to increased risk of asthma in some teenagers

September 17, 2018
Children who take paracetamol during their first two years of life may be at a higher risk of developing asthma by the age of 18, especially if they have a particular genetic makeup, according to new research presented at ...

Cord blood clue to respiratory diseases

September 15, 2018
New research has found children born in the last three months of the year in Melbourne may have a greater risk of developing respiratory diseases such as asthma.

FRESH program combines basic science with social benefits for women at risk of HIV

September 14, 2018
A program established by investigators from the Ragon Institute of Massachusetts General Hospital (MGH), MIT and Harvard is addressing the persistently elevated risk of HIV infection among young women in South Africa from ...

Dietary fiber reduces brain inflammation during aging

September 14, 2018
As mammals age, immune cells in the brain known as microglia become chronically inflamed. In this state, they produce chemicals known to impair cognitive and motor function. That's one explanation for why memory fades and ...

Research reveals link between immunity, diabetes

September 14, 2018
When it comes to diet-induced obesity, your immune system is not always your friend.

Immune response mechanism described for fate determination of T cells

September 13, 2018
After a pathogen infects the body, the immune system responds with a remarkable—and remarkably complicated—cascade of events.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.